Stifel Nicolaus Reiterates "Buy" Rating for Puma Biotechnology Inc (PBYI) – The Cerbat Gem


Post Analyst
Stifel Nicolaus Reiterates "Buy" Rating for Puma Biotechnology Inc (PBYI)
The Cerbat Gem
Puma Biotechnology Inc logo Stifel Nicolaus reaffirmed their buy rating on shares of Puma Biotechnology Inc (NYSE:PBYI) in a report released on Wednesday, April 19th. They currently have a $88.00 target price on the biopharmaceutical company's stock.
Puma Biotechnology (PBYI) Getting Somewhat Positive Press Coverage, Report ShowsTranscript Daily
Puma Biotechnology (PBYI) Getting Somewhat Positive Press Coverage, AlphaOne ReportsMarkets Daily
Puma Biotechnology, Inc. (PBYI) held by 19 SEC 13F Filers | Post ...Post Analyst
Chaffey Breeze -Bibeypost.com -Sports Perspectives
all 22 news articles »

Read more from the original source:
Stifel Nicolaus Reiterates "Buy" Rating for Puma Biotechnology Inc (PBYI) - The Cerbat Gem

Related Posts

Comments are closed.